William J. Chudd
  1. Partner

Mr. Chudd is a partner in Davis Polk’s Corporate Department and a member of the firm’s Mergers and Acquisitions and Private Equity Groups. He is also the co-head of the firm’s Private Equity Group. His diverse and broad-based practice encompasses mergers and acquisitions, private equity transactions, joint ventures, collaborations and other corporate partnering transactions, restructurings, spinoffs, and takeover and corporate governance matters. He regularly represents private equity firms and their portfolio companies in all aspects of their businesses, including acquisitions and dispositions of public and private companies, recapitalizations, minority investments, co-investment arrangements, and formation of private equity funds.

Mr. Chudd also has extensive experience advising multinational corporations on their most critical business initiatives and transactions, including both domestic and cross-border M&A transactions. He has handled matters across many industries, with experience in energy, healthcare, asset management, consumer products, defense, financial services, logistics/transportation services, technology, retail, media and business services sectors.

Work Highlights

Recent Transactions
  • Shire on its:
    • £46 billion acquisition by Takeda
    • $2.4 billion sale of its Oncology business to Servier 
    • $5.2 billion acquisition of NPS Pharma
    • $54 billion proposed acquisition by AbbVie
    • $4.2 billion acquisition of ViroPharma
    • Acquisitions of Foresight Biotherapeutics, Bikam Pharmaceuticals, Lumena Pharmaceuticals, SARcode Bioscience, Lotus Tissue Repair, FerroKin BioSciences and New River Pharmaceuticals
  • Atairos, an independent, private investment firm, in a number of acquisitions and investments, including its investments in Bowlmor AMF and Groupon and series of transactions involving Learfield 
  • Tailwind Capital Partners, a private equity firm, in a number of acquisitions and investments, including of Colony Hardware, MetroGistics, Stratix Corporation, AST and Smith Cooper
  • Cornell Capital, a private equity firm, in a number of acquisitions and investments, including its acquisitions of Frédéric Fekkai Brands and Instant Brands
  • Lockheed Martin in its acquisition of Sikorsky Aircraft
  • ExxonMobil in its acquisition of InterOil and XTO Energy
  • MSCI in its acquisitions of Insignis, IPD Group and RiskMetrics, and its disposition of Institutional Shareholder Services Inc. (ISS)
  • Maidenform in its acquisition by Hanesbrands
  • VF Corporation in its acquisition of The Timberland Company 
  • Federal Reserve Bank of New York and the U.S. Treasury in connection with the recapitalization of American International Group (AIG)
  • Roche in its going-private acquisition of Genentech
  • PartnerRe in its acquisition of ParisRe
  • Warner Chilcott on the amendment to its global collaboration agreement with Sanofi-Aventis
  • AstraZeneca in its acquisition of MedImmune

Recognition

  • Law360 – “Rising Star" in M&A, 2014 and 2016

  • Chambers USA – Corporate/M&A, 2017-2019
  • Chambers USA – "Up and Coming Individual," 2016

Professional History

  • Partner, 2011-present
  • Associate, 2002-2011

    Bar Admissions

    • State of New York

    Education

    • B.S., Cornell University, 1999
    • J.D., Cornell Law School, 2002
      • magna cum laude